Utilization of lipopolysaccharide challenge in cynomolgus macaques to assess IL-10 receptor antagonism

References

• Asiedu C, Guarcello V, Deckard L, Jargal U, Gansuvd B, Acosta E, Thomas J. 2007. Cloning and characterization of recombinant rhesus macaque IL-10/Fc(ala-ala) fusion protein: A potential adjunct for tolerance induction strategies. Cytokine. 40(3):183–192.
   PubMed Web of Science ®Google Scholar
• Benjamin J, Stein A. 2016. The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia. Ther Adv Hematol. 7(3):142–156.
   PubMed Web of Science ®Google Scholar
• Berg DJ, Kühn R, Rajewsky K, Müller W, Menon S, Davidson N, Grünig G, Rennick D. 1995. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest. 96(5):2339–2347.
   PubMed Web of Science ®Google Scholar
• Brooks D, Trifilo M, Edelmann K, Teyton L, McGavern D, Oldstone M. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 12(11):1301–1309.
   PubMed Web of Science ®Google Scholar
• Chen D, Mellman I. 2013. Oncology meets immunology: The cancer-immunity cycle. Immunity. 39(1):1–10.
   PubMed Web of Science ®Google Scholar
• Claser C, de Souza J, Thorburn S, Grau G, Riley E, Renia L, Hafalla J. 2017. Host resistance to plasmodium-induced acute immune pathology is regulated by IL-10 receptor signaling. Infect Immun. 85(6):1–9.
   Web of Science ®Google Scholar
• Cutino-Moguel M, Eades C, Rezvani K, Armstrong-James D. 2017. Immunotherapy for infectious diseases in hematological immunocompromise. Br J Haematol. 177(3):348–356.
   PubMed Web of Science ®Google Scholar
• Dillingh M, van Poelgeest E, Malone K, Kamper E, Stroes E, Moerland M, Burggraaf J. 2014. Characterization of inflammation and immune cell modulation induced by low-dose LPS administration to healthy volunteers. J. Inflamm. 11:1–9.
   Google Scholar
• Döcke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W. 1997. Monocyte deactivation in septic patients: Restoration by IFN-γ treatment. Nat. Med. 3(6):678–681.
   PubMed Web of Science ®Google Scholar
• Erridge C, Bennett-Guerrero E, Poxton I. 2002. Structure and function of lipopolysaccharides. Microbes Infect. 4(8):837–851.
   PubMed Web of Science ®Google Scholar
• Fraker D, Stovroff M, Merino M, Norton J. 1988. Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med. 168(1):95–105.
   PubMed Web of Science ®Google Scholar
• Gallagher P, Lowe G, Fitzgerald T, Bella A, Greene C, McElvaney N, O'Neill S. 2003. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax. 58(2):154–156.
   PubMed Web of Science ®Google Scholar
• Geginat J, Larghi P, Paroni M, Nizzoli G, Penatti A, Pagani M, Gagliani N, Meroni P, Abrignani S, Flavell RA. 2016. The light and the dark sides of IL-10 in immune-mediated diseases and cancer. Cytokine Growth Factor Rev. 30:87–93.
   PubMed Web of Science ®Google Scholar
• Grutz G. 2005. New insights into the molecular mechanism of IL-10-mediated immunosuppression. J. Leukocyte Biol. 77:3–15.
   PubMed Web of Science ®Google Scholar
• Guiducci C, Vicari A, Sangaletti S, Trinchieri G, Colombo M. 2005. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res. 65(8):3437–3446.
   PubMed Web of Science ®Google Scholar
• Jakobshagen K, Ward B, Baschuk N, Huss S, Brunn A, Malecki M, Fiolka M, Rappl G, Corogeanu D, Karow U, et al. 2015. Endogenous IL-10 alleviates systemic anti-viral cellular immune response and T-cell-mediated immunopathology in select organs of acutely LCMV-infected mice. Am J Pathol. 185(11):3025–3038.,
   PubMed Web of Science ®Google Scholar
• Ji X, Sun K, Feng Y, Yin G. 2004. Changes of inflammation-associated cytokine expressions during early phase of experimental endotoxic shock in macaques. World J Gastroenterol. 10(20):3026–3033.
   PubMed Web of Science ®Google Scholar
• Leturcq D, Moriarty A, Talbott G, Winn R, Martin T, Ulevitch R. 1996. Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest. 98(7):1533–1538.
   PubMed Web of Science ®Google Scholar
• Li S, Liu T, Goldman N. 1990. Cis-acting elements responsible for IL-6-inducible C-reactive protein gene expression. J Biol Chem. 265(7):4136–4142.
   PubMed Web of Science ®Google Scholar
• Lopez-Collazo E, del Fresno C. 2013. Pathophysiology of endotoxin tolerance: Mechanisms and clinical consequences. Crit Care. 17(6):242
   PubMed Web of Science ®Google Scholar
• Lynn M, Rossignol DP, Wheeler JL, Kao RJ, Perdomo CA, Noveck R, Vargas R, D'Angelo T, Gotzkowsky S, McMahon FG. 2003. Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia. J Infect Dis. 187(4):631–639.
   PubMed Web of Science ®Google Scholar
• Mahon R, Hafner R. 2017. Applying precision medicine and immunotherapy advances from oncology to host-directed therapies for infectious diseases. Front Immunol. 8:688.
   PubMed Web of Science ®Google Scholar
• Mannino M, Zhu Z, Xiao H, Bai Q, Wakefield M, Fang Y. 2015. The paradoxical role of IL-10 in immunity and cancer. Cancer Lett. 367(2):103–107.
   PubMed Web of Science ®Google Scholar
• Moore K, de Waal Malefyt R, Coffman R, O'Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 19:683–765.
   PubMed Web of Science ®Google Scholar
• Newton MR, Askeland EJ, Andresen ED, Chehval VA, Wang X, Askeland RW, O'Donnell MA, Luo Y. 2014. Anti-IL-10R1 monoclonal antibody in combination with bacillus Calmette-Guerin is protective against bladder cancer metastasis in a murine orthotopic tumor model and demonstrates systemic specific anti-tumor immunity. Clin Exp Immunol. 177(1):261–268.
   PubMed Web of Science ®Google Scholar
• Pestka S, Krause C, Sarkar D, Walter M, Shi Y, Fisher P. 2004. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol. 22:929–979.
   PubMed Web of Science ®Google Scholar
• Picha K, Tam S, Khandekar V, Soderman A, Martin E, Jordan R, Bugelski P. 2004. Effects of LPS on toxicologically-important endpoints in cynomolgus macaques. Preclinica. 2:427–434.
   Google Scholar
• Polk B, Rosenwasser L. 2017. Biological therapies of immunologic diseases: Strategies for immunologic interventions. Immunol Allergy Clin North Am. 37(2):247–259.
   PubMed Web of Science ®Google Scholar
• Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, Volk H. 1995. Mechanism of endotoxin desensitization: Involvement of IL-10 and TGFβ. J Exp Med. 181(5):1887–1892.
   PubMed Web of Science ®Google Scholar
• Saraiva M, O'Garra A. 2010. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 10(3):170–181.
   PubMed Web of Science ®Google Scholar
• Schaaf BM, Boehmke F, Esnaashari H, Seitzer U, Kothe H, Maass M, Zabel P, Dalhoff K. 2003. Pneumococcal septic shock is associated with the IL-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med. 168(4):476–480.
   PubMed Web of Science ®Google Scholar
• Tian G, Li J, Wang D, Zhou D. 2014. Targeting IL-10 in autoimmune diseases. Cell Biochem Biophys. 70(1):37–49.
   PubMed Web of Science ®Google Scholar
• van der Poll T, Jansen J, Levi M, ten Cate H, Hack CE, Aarden LA, ten Cate JW, van Deventer SJ. 1996. Interleukin-10 release during endotoxemia in chimpanzees: Role of platelet-activating factor and IL-6. Scand J Immunol. 43(1):122–125.
   PubMed Web of Science ®Google Scholar
• Vicari AP, Chiodoni C, Vaure C, Aït-Yahia S, Dercamp C, Matsos F, Reynard O, Taverne C, Merle P, Colombo MP, et al. 2002. Reversal of tumor-induced dendritic cell paralysis by CpG immuno-stimulatory oligonucleotide and anti-IL-10 receptor antibody. J Exp Med. 196(4):541–549.
   PubMed Web of Science ®Google Scholar
• Vinh D. 2014. Cytokine immunomodulation for the treatment of infectious diseases: Lessons from primary immunodeficiencies. Exp Rev Clin Immunol. 10(8):1069–1100.
   PubMed Web of Science ®Google Scholar
• Wagner T, Horton V, Carlson G, Myhre P, Gibson S, Imbertson L, Tomai M. 1997. Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609, and S-28463. Cytokine. 9(11):837–845.
   PubMed Web of Science ®Google Scholar
• Whiteside T, Demaria S, Rodriguez-Ruiz M, Zarour H, Melero I. 2016. Emerging opportunities and challenges in cancer immunotherapy. Clin Cancer Res. 22(8):1845–1855.
   PubMed Web of Science ®Google Scholar